IRRAS AB announced that the first patient in the United States was successfully treated with IRRAflow, the company's initial product that offers an innovative, therapeutic approach to the fluid management of patients with intracranial bleeding. This first IRRAflow patient treatment in the US was performed at the University of California ­ Irvine (UCI) Medical Center, located in Orange, California. The team, led by UCI Health neurosurgeon Dr. Sumeet Vadera, successfully treated a patient suffering from a chronic subdural hematoma that formed after a recent fall.